SprintRay introduces new Midas Digital Press 3D printer with Resin Capsule
Designed to handle highly viscous resins - specifically for the dental industry - that traditional 3D printing technologies cannot
SprintRay, a company developing 3D printing technology for the dental industry, has introduced its ‘most significant innovation yet’ – the Midas Digital Press 3D printer. The system introduces the world to Digital Press Stereolithography (DPS) and the company’s patent-pending Resin Capsule System – designed to handle highly viscous resins that traditional 3D printing technologies cannot.
Midas and DPS eliminate viscosity limitations and create a new material innovation platform. The patented process removes the boundaries chemists have previously faced to change the mechanical properties and aesthetics of resin. Midas uses a unique, vacuum-sealed resin capsule that simplifies the workflow and allows for the printing of up to three units in just minutes – offering a clean and efficient process.
“Materials, more than anything, have dictated what is possible in the dental restoration field,” said Amir Mansouri, Co-founder and CEO of SprintRay. “The introduction of Midas revolutionizes both the manner in which material is transformed and reveals an entirely new paradigm of what can actually be printed. Until now, materials like ceramics were too thick for traditional 3D printers to handle. Midas changes everything. Not only does this innovation handle today’s ceramic-based materials but sets the stage for future advances in composites and ceramics. We are on the brink of a new era in biomaterial innovation, and we’re thrilled to be leading the charge.”
Alongside the printer, SprintRay has launched its AI Studio design software to streamline the chairside design and delivery of restorations. AI Studio software integrates seamlessly with existing dental scanning systems like 3Shape, Dexis, and Medit. This cloud-based platform allows for easy adjustments and customizations without needing any CAD skills.
“Midas has changed what we view as possible in 3D printed materials. This new open platform allows an entire industry of material science innovators to explore a new galaxy of solutions. Biomaterials have a very exciting future that is going to result in monumental benefits for our customers and patients alike,” said Ehsan Barjasteh, Head of the SprintRay Biomaterial Innovation Lab.
SprintRay expects to start delivering the Midas Digital Press 3D printers by the end of 2024.
